Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export

Lei, Peng, Ayton, Scott, Finkelstein, David I, Spoerri, Loredana, Ciccotosto, Giuseppe D, Wright, David K, Wong, Bruce X W, Adlard, Paul A +9 more·2012·Nature Medicine
DOI 10.1038/nm.2613

Cited by (596)

Items 501–596 of 596

  1. Hybrid Antioxidant and Metal Sequestering Small Molecules Targeting the Molecular Features of Alzheimer’s Disease
    Kayla N. Green, Hannah M. Johnston, Marianne E. Burnett, Samantha M. Brewer · 2016 · Comments on Inorganic Chemistry
  2. A Possible Mechanism for the Propagation of Pathological Proteins in Parkinson’s Disease
    2015 · Journal of Parkinson’s Disease and Alzheimer’s Disease
  3. Dysregulation of Neuronal Iron in Alzheimer’s Disease
    Md. Sahab Uddin, Ghulam Md Ashraf · 2021 · Current Neuropharmacology
  4. Tau Immunotherapy
    Einar M. Sigurdsson · 2016 · Methods in pharmacology and toxicology
  5. Might Diet, APOE-APOA1 Axis, and Iron Metabolism Provide Clues About the Discrepancy in Alzheimer’s Disease Occurrence Between Humans and Chimpanzees? A Bioinformatics-Based Re-Analysis of Gene Expression Data on Mice Fed with Human and Chimpanzee Diets
    Ashok Kumar, Amit Pal, Parminder Singh, Isha Rani, Vincenzo Tondolo, Mauro Ciro Antonio Rongioletti, Rosanna Squitti · 2023 · Biological Trace Element Research
  6. Nouvelle stratégie de neuroprotection basée sur la chélation conservatrice du fer dans la maladie de Parkinson
    Caroline Moreau, Anne‐Sophie Rolland, P. Guyon, Jean-Christophe Devedjian, Dominique Deplanque, Régis Bordet, Nicolas Carrière, Luc Defebvre, David Devos · 2019 · Bulletin de l Académie Nationale de Médecine
  7. Dynamics of Iron Homeostasis in Health and Disease: Molecular Mechanisms and Methods for Iron Determination
    Christina Ploumi, Emmanouil Kyriakakis, Nektarios Tavernarakis · 2019 · Series in bioengineering
  8. Magnetic Susceptibility and Area in the Subthalamic Nucleus Measured by QSM for Diagnosis of Progressive Supranuclear Palsy
    Shotaro Haji, Wataru Sako, Kenta Hanada, Tomoyasu Matsubara, Yusuke Osaki, Yuki Matsumoto, Masafumi Harada, Yuishin Izumi · 2025 · Movement Disorders Clinical Practice
  9. Herbacetin alleviates Parkinson's disease by inhibiting ferroptosis in PC12 cells through the Nrf2/GPX4 pathway
    Yu Liu, Yaru Wang, Junmin Xi, Jianguo Fang · 2025 · Bioorganic Chemistry
  10. Diagnosis of cognitive impairment in chronic kidney disease: A radiomics and machine learning approach with quantitative susceptibility mapping
    Yifan Guo, Yuanzhe Li, Yu Qi, Xu Liu, Li-jun Song, Wen-bo Yang, Min-Gan Li, Xiao‐Yan Bai, Mao-sheng Xu, Meng-yuan Shen et al. · 2026 · Brain Research Bulletin
  11. Eisen im alternden Gehirn
    Clemens Küpper, Johannes Levin, Thomas Klopstock · 2017 · Neuroradiologie Scan
  12. The disorder of the iron metabolism as a possible mechanism for the development of neurodegeneration after new coronavirus infection of SARS-CoV-2
    Igor Litvinenko, Красаков Игорь Вячеславович · 2021 · Russian Military Medical Academy Reports
  13. Targeting Transition Metals for Neuroprotection in Alzheimer’s Disease
    Scott Ayton, Abdel Ali Belaidi, Peng Lei, Ashley Ian Bush · 2017 · Elsevier eBooks
  14. Iron Depletion Reduces Abce1 Transcripts While Inducing the Mitophagy Factors Pink1 and Parkin
    Jana Key, Nesli-Ece Şen, Aleksandar Arsović, Stella Krämer, Robert Hülse, Suzana Gispert-Sánchez, Georg W. J. Auburger · 2019 · Preprints.org
  15. Anti-amyloid Monoclonal Antibodies for Alzheimer’s Disease: A New Hope? (Review)
    И. А. Мазеркина · 2025 · Safety and Risk of Pharmacotherapy
  16. Systematic Review and Meta-Analysis on Heavy Metals and Trace Elements in Mild Cognitive Impairment
    Yaxin Dong, Lu Ren, Tianran Tang, Xinyi Zhang, Dan Han, Yingyi Luo, Liqiang Wang, Zonghui Cui, Sheng Yuan Ji, Jianheng Zheng et al. · 2025 · Biological Trace Element Research
  17. Tau protein as a regulator of mitochondrial function and dynamics
    Eleni N. Tsakiri, Carlos Campos‐Marques, Christina Ploumi, Kalliopi Skourti, Antonis Roussos, Eirini Mytilinaiou, Anastasia Vamvaka-Iakovou, Ildete L. Ferreira, Chrysoula Dioli, Despoina D. Gianniou et al. · 2026 · Proceedings of the National Academy of Sciences
  18. Pathogenesis of neurodegenerative diseases via templated recruitment
    Jing Guo · 2013 · ScholarlyCommons (University of Pennsylvania)
  19. Investigating some Selected Heavy Metals and Micronutrients Levels in Herbal Preparation Marketed in Nigeria: A Pilot Study
    Augustine Anayochukwu Onyeaghala, I. Omotosho, A. Shivashankara · 2015 · Journal of Pharmaceutical Research International
  20. Iron in Eukarya
    Paul Sharp · 2014 · Royal Society of Chemistry eBooks
  21. Polymorphism of Tau Fibrils
    Yoshiaki Furukawa · 2013 · Elsevier eBooks
  22. Antisense oligonucleotide drugs for neurological and neuromuscular disease
    Roger M. Lane, C. Frank Bennett · 2020 · Elsevier eBooks
  23. Targeting ferroptosis as a potential prevention and treatmentstrategy for human diseases
    Xin Shen, Yingying Yu, Junyi Chen, Jie Shen, Jinming Zhang, Fudi Wang, Junxia Min · 2022 · Scientia Sinica Vitae
  24. Tau Modulates Neurovascular Coupling
    Fei Tang, Qing Wang, Jun Guo, Peng Lei · 2021 · Neuroscience Bulletin
  25. Iron Homeostasis and Neurodegeneration
    Robert R. Crichton · 2016
  26. Targeted degradation of microtubule-associated protein tau using an engineered nanobody-E3 ubiquitin ligase adapter fusion
    Shiyao Wang, Shaowei Jiang, Guoan Zheng, Yong Ku Cho · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  27. Mental Health and Cognitive Function
    Paul Sharp, Peter J Rogers, Helene McNulty, Kenneth Richard Fox · 2017 · Wiley eBooks
  28. Tau Ablation Rewires Brain Cell Programs in Health and Restores Function in Disease
    Chimal-Juárez, Enrique, Patel, Henika, Jury-Garfe, Nur, Dabin, Luke C., Vidal, Ruben, Kim, Jungsu, Lasagna-Reeves, Cristian A. · 2026 · bioRxiv
  29. Characterising transgenic APP mutation mouse models of amyloid pathology for use in preclinical immunotherapy
    Martha Hvoslef‐Eide · 2012 · ORCA Online Research @Cardiff (Cardiff University)
  30. Progressive models of Parkinson's disease : behavioural and neurochemical analyses
    Alexandra Alvarsson · 2015 · Figshare
  31. Network modeling to identify new mechanisms and therapeutic targets for Parkinson’s disease
    Linda H. MacArthur, Habtom W. Ressom, Salim Shah, Howard J. Federoff · 2013 · Expert Review of Neurotherapeutics
  32. Functional implications of tau-fyn interactions in Alzheimer's disease
    Hay Wun Dawn Lau · 2015
  33. Development of magnetic resonance imaging techniques for mouse models of Alzheimer's Disease
    James M. O’Callaghan · 2015 · UCL Discovery (University College London)
  34. Gene-Environment Interactions Between Manganese Toxicity and Early-Onset Parkinson's Disease Genes
    Sudipta Chakraborty · 2015
  35. Utjecaj sistemske upale na homeostazu željeza u egzacerbaciji i stabilnoj fazi kronične opstrukcijske plućne bolesti
    Leida Tandara · 2016 · Repozitorij Farmaceutsko-biokemijskog fakulteta (Sveučilišta u Zagrebu)
  36. Molecular Aspects of Concussion and Chronic Traumatic Encephalopathy
    A. A. Farooqui · 2018 · Elsevier eBooks
  37. Investigating the role of cua-1 in maintaining copper homeostasis within a long-lived, insulin-signalling, C. elegans mutants
    Katherine Ganio · 2017 · Minerva Access (University of Melbourne)
  38. Nouvelle stratégie de neuroprotection basée sur la chélation conservatrice du fer dans la maladie de Parkinson
    Anne‐Sophie Rolland, C. Moreau, Jean-Christophe Devedjian, Dominique Deplanque, Régis Bordet, Nicolas Carrière, Luc Defebvre, David Devos · 2019 · Pratique Neurologique - FMC
  39. Molekularne podłoże proteinopatii: przyczyna zespołów otępiennych i zaburzeń motorycznych
    Emilia Zgórzyńska, Klaudia Krawczyk, Patrycja Bełdzińska, Anna Walczewska · 2021 · Postępy Higieny i Medycyny Doświadczalnej
  40. THE ROLE OF MICROTUBULE-ASSOCIATED PROTEIN TAU IN NEURONAL EXCITABILITY AND EPILEPTOGENESIS
    Ryan Cloyd · 2021 · UKnowledge (University of Kentucky)
  41. INVESTIGATION INTO THE FUNCTIONAL ROLES OF TAU AND ALPHA-SYNUCLEIN IN NEURODEGENERATIVE DISEASE
    Meaghan Morris · 2014
  42. Ferroptosis Promotes Microtubule-Associated Protein Tau Aggregation via GSK-3β Activition and Proteasome Inhibition
    Shaohui Wang, Yao Xing Jiang, Yabo Liu, Qianhui Liu, Hongwei Sun, Mengjie Mei, Xiaomei Liao · 2021 · Research Square
  43. Faculty Opinions recommendation of Ferroptosis: an iron-dependent form of nonapoptotic cell death.
    Yuichiro Suzuki · 2012 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  44. Mitochondrial dysfunction and its consequences in the context of neurodegeneration
    Jana Key · 2021
  45. Extracellular Tau Oligomers Induce Disruption of Endogenous Tau Distribution, Invasion of Tau into the Somatodendritic Compartment and Axonal Transport Dysfunction
    Eric C Swanson · 2017
  46. Literature-based predictions of treatments for genetic disease pathology
    Cole A. Deisseroth, Won‐Seok Lee, Ji‐Yoen Kim, Hyun-Hwan Jeong, Julia Wang, Huda Yahya Zoghbi, Zhandong Liu · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  47. Emerging Therapeutic Approaches for Neurodegenerative Diseases
    Rajesh Ramesh Ugale, Lopmudra P. Sarode · 2022 · BENTHAM SCIENCE PUBLISHERS eBooks
  48. Efeito do cloreto de lítio no modelo de Doença de Parkinson por 6-OHDA.
    Ana Flavia Tostes da Silva · 2021
  49. The Critical Roleplay of Iron Neurochemistry in Progression of Parkinson’s Disease
    Garima Sharma, Monika Kadian, Kritika Sharma, Shivani Pandita, Kanishka Shrivasatava, Anil Kumar · 2022 · Nutritional neurosciences
  50. Antioxidant dihydrolipolic acid protects against aluminum-induced toxicity in Alzheimer's model
    Sonia Sanajou, Anıl Yirün, Göksun Demirel, Deniz Arca Çakır, Gönül Şahin, Pınar Erkekoğlu, Terken Baydar · 2023 · Research Square
  51. Literature-based predictions of Mendelian disease therapies
    Cole A. Deisseroth, Won‐Seok Lee, Jiyoen Kim, Hyun-Hwan Jeong, Ryan S. Dhindsa, Julia Wang, Huda Yahya Zoghbi, Zhandong Liu · 2023 · The American Journal of Human Genetics
  52. Ferroptosis in Central Nervous System Hypoxia–Ischemia
    Namood-e Sahar, Eric S. Peeples · 2023 · Springer eBooks
  53. Antisense oligonucleotide drugs for neurological and neuromuscular diseases
    Roger M. Lane, C. Frank Bennett · 2024 · Elsevier eBooks
  54. Copy number variations of proteins associated with neurodegenerative diseases and rare neurological disorders
    Zhangzhong Yang, Peng Lei · 2024 · Scientia Sinica Vitae
  55. Hücre Ölüm Mekanizması Ferroptozun Alzheimer Patogenezindeki Rolü
    Hilal Koyuncu, Tülay Keskin, Şengül Tural · 2024 · Doğal Yaşam Tıbbı Dergisi
  56. Combinatorial mechanisms specify cellular location and neurotransmitter identity during regeneration of planarian neurons
    Kendall B. Clay, Taylor Medlock-Lanier, Rachel Grimes, Olabamibo O. Oke, Nikolay M. Filipov, Rachel H. Roberts-Galbraith · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  57. The impact of tau deletion on Huntington’s disease: An in vivo perspective
    Eva Lepinay, Martine Saint‐Pierre, Maxime Teixeira, Marta Snapyan, Abid Oueslati, Martin Parent, Melanie Alpaugh, Francesca Cicchetti · 2025 · Molecular Therapy
  58. Etude de la dynamique de tau dans le compartiment synaptique dans un contexte physiologique et pathologique exemple de la maladie d'Alzheimer
    Marie‐Lise Frandemiche · 2013 · theses.fr (ABES)
  59. Additional file 1 of Triglyceride-glucose index as a valuable predictor for aged 65-years and above in critical delirium patients: evidence from a multi-center study
    Xiaxuan Huang, Hongtao Cheng, Yuan, Shiqi, Yitong Ling, Shanyuan Tan, Tang, Yonglan, Niu, Chen, Lyu, Jun · 2023 · Figshare
  60. Additional file 1 of Association of triglyceride-glucose index and delirium in patients with sepsis: a retrospective study
    Yipeng Fang, Dou, Aizhen, Shen, Yuehao, Tianyu Li, Haiying Liu, Cui, Yan, Xie, Keliang · 2024 · Figshare
  61. Additional file 1 of Different MAPT haplotypes influence expression of total MAPT in postmortem brain tissue
    Tauber, Christina V., Sigrid C. Schwarz, Thomas W. Rösler, Arzberger, Thomas, Gentleman, Steve, Otto Windl, Mandy Krumbiegel, Reis, André, Viktoria Ruf, Jochen Wolfgang Herms et al. · 2024 · Figshare
  62. Additional file 2 of Different MAPT haplotypes influence expression of total MAPT in postmortem brain tissue
    Tauber, Christina V., Sigrid C. Schwarz, Thomas W. Rösler, Arzberger, Thomas, Gentleman, Steve, Otto Windl, Mandy Krumbiegel, Reis, André, Viktoria Ruf, Jochen Wolfgang Herms et al. · 2024 · Figshare
  63. Additional file 2 of Ultrasensitive assays for detection of plasma tau and phosphorylated tau 181 in Alzheimer’s disease: a systematic review and meta-analysis
    Ding, Xulong, Zhang, Shuting, Lijun Jiang, Wang, Lu, Li, Tao, Lei, Peng · 2021 · Figshare
  64. Additional file 1 of Tau modulation through AAV9 therapy augments Akt/Erk survival signalling in glaucoma mitigating the retinal degenerative phenotype
    Kanishka Pushpitha Maha Thananthirige, Chitranshi, Nitin, Devaraj K. Basavarajappa, Rashi Rajput, Mojdeh Abbasi, Viswanthram Palanivel, Gupta, Veer Bala, Paulo, Joao A., Maya Koronyo‐Hamaoui, Mirzaei, Mehdi et al. · 2024 · Figshare
  65. Additional file 1 of Tau reduction attenuates autism-like features in Fmr1 knockout mice
    Zhao, Shanshan, Xiangyu Jiang, Linkun Han, Jiang, Yiru, Wang, Yong, Jian Meng, Xiang Zhu, Zhang, Xian, Hong Luo, Zhang, Yun-wu · 2023 · Figshare
  66. Additional file 1 of Ultrasensitive assays for detection of plasma tau and phosphorylated tau 181 in Alzheimer’s disease: a systematic review and meta-analysis
    Ding, Xulong, Zhang, Shuting, Jiang, Lijun, Wang, Lu, Li, Tao, Lei, Peng · 2021 · Figshare
  67. Epothilone B stabilizes microtubules via Tau to protect retinal ganglion cells and promote axon regeneration
    Yang Liang, Jing Chi, Ying-Jian Sun, Yun-zhi Li, Guang-Yu Li, Guang-Yu Li · 2026 · Cell Communication and Signaling
  68. Selective disruption of tau–SH3 interactions rescues seizure and sleep phenotypes
    Mayank Shandilya, Anne Koutures, Kwaku Addo-Osafo, Kaylin Hwang, Mariane Cristine Vicente, Ashley N. Ewens, Brittany M. Katz, Sam Peters, Jessica M. Choquette, Rahil N. Vaknalli et al. · 2026 · Brain
  69. Génération de cellules souches pluripotentes induites de patients Alzheimer et production d'un modèle de culture en trois dimensions de neurones pour les recherches diagnostiques et thérapeutiques de la maladie d’Alzheimer
    Laura Auboyer · 2018 · theses.fr (ABES)
  70. Regulation of neuronal microtubule-based transport by polyglutamylation
    Satish Bodakuntla · 2019
  71. Cellular modelling of a new type of Pontocerebellar Hypoplasia caused by a defect in the multiple inositol-polyphosphate phosphatase 1 gene
    Ekin Ucuncu · 2020 · theses.fr (ABES)
  72. Systematic characterization of a large number of Microtubule-Associated Proteins using purification-free TIRF-reconstitution assays
    A. S. Jijumon · 2021 · theses.fr (ABES)
  73. Endothelial adenosine A2A receptor activation-mediated Tau hyperphosphorylation leads to blood–brain barrier breakdown in a chronic methamphetamine mouse model
    Ying Qian, Meigui Hu, Xingxing Xie, Li Ren, Xiaorong Huang, Shanshan Hu · 2026 · Frontiers in Medicine
  74. Characterising the role of alpha synuclein in Ferroptosis, in the context of Parkinson's Disease
    Laura Mahoney‐Sanchez · 2022
  75. Caractérisation et modulation du microbiote intestinal dans le contexte de la maladie d’Alzheimer : vers une nouvelle piste thérapeutique
    Caroline Ismeurt · 2021 · theses.fr (ABES)
  76. Rôle du métabolisme des acides gras polyinsaturés et du fer dans la vulnérabilité des neurones dopaminergiques à la ferroptose : nouvelles approches pharmacologiques pour la maladie de Parkinson.
    Hind Bouchaoui · 2024
  77. Atypical involvement of Alzheimer’s tau proteins in diseases beyond tauopathies
    Jie Meng, Zijie Deng, Jing Zhang, Wenxin Yu, Xiaolei Wu, Peng Lei · 2026 · Life Medicine
  78. TARDBP Mediates the MAP 3 K 11/ SLC 3 A 2/ GPX 4 Axis in Alzheimer's Disease Rats by Enhancing KRAS m RNA Stability
    QiTao Zhao, Yadong Yu, FuJiang Wang, Ya Wang, Peng Shao, LianDong Zhao · 2026 · Journal of Cellular and Molecular Medicine
  79. Exploring and Targeting the Connection of Iron and Copper Homeostasis to Neurodegenerative Diseases
    Xin Liu, Lin Jia, Kerong Wu, Mo Chen, Ji-Chao Sun, Chuanbin Yang, Cheng-Chao Xu, Jie Sun, Ji-Gang Wang, Lingyun Dai · 2026 · MedComm
  80. Tau reduction counteracts transcriptomic and behavioral abnormalities in an Alzheimer amyloid model
    Sara J. Knowles, Cathrine Sant, Pranav Nambiar, Rafaella Araujo Gonçalves, Kaitlyn Ho, Gui-Qiu Yu, Reuben Thomas, Megumi Mori, Lane Domke, Victor Huang et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  81. XunZi, an AI biologist, reveals disease-modifying targets
    Xu‐Dong Huang, Junhong Qin, Fei Tang, Chenyu Yang, Linhua Xu, Junfen Wei, Dan Liu, Kang Chen, Chi Zhang, Miaomiao Chen et al. · 2026 · Nature Biomedical Engineering
  82. Metal ion dyshomeostasis in neurological disorders: from pathological mechanisms to targeted neuroprotective and regenerative strategies
    Mengqiang Yao, Chunlei Xing, Xin Li, Xiaochen Sun, Chenxi Zhang, Xingji You, Su Li · 2026 · Frontiers in Pharmacology
  83. Alzheimer Hastalığında Aβ ve Tau'nun İkili Doğası: Sinaptik Budama, Aktin Disfonksiyonu ve Homeostatik Restorasyon
    Hilal Karakurt, Merve Yunak, Fahrettin Afşin Sarı, Aybars Kökçe · 2026 · OSMANGAZİ JOURNAL OF MEDICINE
  84. Tau-targeting pharmacological strategies in neurodegenerative disease
    Hanyuan Zheng, Jie Zheng · 2026 · Trends in Pharmacological Sciences
  85. Metals in Alzheimer's Disease
    Christopher Oloruntoba Akintayo, Joseph Oluwatomi Akintayo, Seyifunmi Chibuikem Elufowoju, Faustina Chiamaka Irozulike, Abraham Olufemi Asuku, Daniel Ojodale Francis, Eghe Jovita Egharevba, Chikere Owen Udeh, Ayodele Benson, Chidiebere Catherine Anieze · 2026 · IGI Global eBooks
  86. Poly (Lipoic Acid) Nanoparticles With High Blood‐Brain Barrier Permeability and Enhanced Anti‐Ferroptotic Activity for Ischemic Stroke Treatment
    Qing‐zhang Tuo, Juan Tan, Hong-Fa Yan, Xueying Zhou, Peng Lei, Shiyong Zhang · 2026 · Small
  87. Metal Ions and Protein Aggregation: Unraveling Molecular Interactions and Theranostic Prospects in Proteinopathies
    Danilo Milardi, Jiyeon Han, Hyuck Jin Lee, Feng Ding, Yifat Miller, Peter Faller, Ashley Ian Bush, Peter John Crouch, David Isaac Finkelstein, Kay L. Double et al. · 2026 · Chemical Reviews
  88. Therapeutic targeting of tauopathies: From druggable biology to precision intervention
    Chengjia Zhang, Jialiang Ma, Xinruo Wu, Xingyi Wang, Xiaohua Huang, Honghua Zheng, Yingjun Zhao · 2026 · Pharmacological Research
  89. Ferroptosis-driven inflammaging in age-associated degenerative disorders: Molecular mechanisms and therapeutic potential of natural products
    Deepa S. Mandlik, Satish K. Mandlik · 2026 · Ageing Research Reviews
  90. Circular RNAs in Alzheimer’s Disease: Mechanisms, Biomarkers, and EPAC Signalling in Ferroptosis
    Mert Yüksel, Martina Schmidt · 2026 · Antioxidants
  91. Basal Ganglia Iron Accumulation Mediates Stage-Dependent Associations Between Plasma pTau217 and Hippocampal Atrophy in Alzheimer’s Disease
    Pengbo Gao, Haoye Tan, Guangshi Li, Jinxia Liang, Mingfeng Yang, Danyan Xu, Qiang Wang, Shuang Liang, Zhidai Xiao, Xiaomin Zheng et al. · 2026 · Research Square
  92. Herbal bioactive compounds modulating ferroptosis and pyroptosis in neonatal hypoxic-ischemic brain injury: a systematic review of molecular basis, proposed crosstalk, and translational challenges
    Xinyang Zhang, Hio Lam Ho, Zhong‐Ping Feng, Hong‐Shuo Sun · 2026 · Phytomedicine
  93. A putative iron-related evolving framework in Alzheimer's disease: From iron dyshomeostasis and ferro-aging to ferroptosis
    Daman Tian, Ting Shi, Shuangfeng Xu, Junfeng Lan, Manyan Zhao, 吴红艳, Jiao Yang, Zhifeng Wang, Jian Wang · 2026 · Journal of Alzheimer s Disease
  94. BindingDB Entry 50002434: Small-Molecule Activator of UNC-51-Like Kinase 1 (ULK1) That Induces Cytoprotective Autophagy for Parkinson's Disease Treatment.
    BindingDB · 2020 · UC San Diego
  95. BindingDB Entry 50042999: Progress and developments in tau aggregation inhibitors for Alzheimer disease.
    BindingDB · 2014 · UC San Diego
  96. Modifications of the tau protein and their varied effects on aggregation and function
    Benjamin Combs · 2013 · KU ScholarWorks (The University of Kansas)